Publications | Page 4 | Cervo Brain Research Centre

Export 16 results:

Filters: Keyword is Middle Aged and Author is Chantal Mérette [Clear All Filters]

2014

Harvey AG, Bélanger L, Talbot L, Eidelman P, Beaulieu-Bonneau S, Fortier-Brochu É, et al. Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. J Consult Clin Psychol. 2014;82(4):670-83.

Morin CM, Leblanc M, Ivers H, Bélanger L, Mérette C, Savard J, et al. Monthly fluctuations of insomnia symptoms in a population-based sample. Sleep. 2014;37(2):319-26.

Morin CM, Beaulieu-Bonneau S, Ivers H, Vallières A, Guay B, Savard J, et al. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701-7.

2013

Macoir J, Fossard M, Mérette C, Langlois M, Chantal S, Auclair-Ouellet N. The role of basal ganglia in language production: evidence from Parkinson's disease. J Parkinsons Dis. 2013;3(3):393-7.

2011

Morin CM, LeBlanc M, Bélanger L, Ivers H, Mérette C, Savard J. Prevalence of insomnia and its treatment in Canada. Can J Psychiatry. 2011;56(9):540-8.

2009

Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-15.

LeBlanc M, Mérette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32(8):1027-37.

Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169(5):447-53.

Klempan TA, Rujescu D, Mérette C, Himmelman C, Sequeira A, Canetti L, et al. Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7):934-43.

2008

Chagnon YC, M-A Roy, Bureau A, Mérette C, Maziade M. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. Schizophr Res. 2008;100(1-3):281-90.

2007

Beaulieu-Bonneau S, LeBlanc M, Mérette C, Dauvilliers Y, Morin CM. Family history of insomnia in a population-based sample. Sleep. 2007;30(12):1739-45.

Chagnon YC, Bureau A, Gendron D, Bouchard RH, Mérette C, M-A Roy, et al. Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(8):1063-9.

LeBlanc M, Beaulieu-Bonneau S, Mérette C, Savard J, Ivers H, Morin CM. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J Psychosom Res. 2007;63(2):157-66.

2003

Lehoux C, Everett J, Laplante L, Emond C, Trépanier J, Brassard A, et al. Fine motor dexterity is correlated to social functioning in schizophrenia. Schizophr Res. 2003;62(3):269-73.

M-A Roy, Lehoux C, Emond C, Laplante L, Bouchard R-, Everett J, et al. A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia. Schizophr Res. 2003;62(1-2):155-63.

2000

Bouchard RH, Mérette C, Pourcher E, Demers M-, Villeneuve J, Roy-Gagnon MH, et al. Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group. J Clin Psychopharmacol. 2000;20(3):295-304.

Funding / Support / Partners

© Gouvernement du Québec